Crinetics Pharmaceuticals
Price & Volume
Stats
See more52W Range | $24.10-$62.53 |
Market Cap | $2.7B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | -59.6% |
Gross Profit (12 Mos) | -$239.1M |
Diluted EPS | -$3.69 |
News
See moreYahoo Finance • 2 days ago
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
Yahoo Finance • 2 days ago
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 16 days ago
Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly
Yahoo Finance • last month
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. R. Scott Struthers Ph.D. |
Address | 6055 Lusk Boulevard, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 437 |
